Skip to main content

Table 2 DEGs in pCR and relapse groups

From: Prediction of prognostic signatures in triple-negative breast cancer based on the differential expression analysis via NanoString nCounter immune panel

 Gene

aP-value

bpCR DEG

 IL2RA

2.34E-07

 CCL5

1.17E-06

 SELE

1.71E-04

 CCL20

1.67E-05

 FCER1A

7.49E-04

 CD1A

8.26E-05

 HAMP

3.35E-04

 CD7

5.12E-04

 C4A.B

1.34E-04

cRELAPSE DEG

 CCL5

9.49E-06

 vCCL7

9.85E-06

 TNFSF13B

5.80E-05

 CSF2RB

1.60E-04

 CLEC4E

2.73E-04

 CCL8

3.58E-04

 SELE

3.97E-04

 EDNRB

4.34E-04

 IL17B

5.75E-04

 IL2RA

7.44E-04

 FCER1A

8.09E-04

 TGFBI

1.07E-03

 GZMB

1.12E-03

  1. Only genes at FDR < 0.05 after multiple hypothesis testing are presented
  2. a: Original P value calculated in edgeR
  3. b, c: DEGs in pCR and relapse conditions respectively
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us